Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab

S. Hongeng; P. Tardtong; S. Worapongpaiboon; A. Ungkanont; S. Jootar

doi:10.1038/sj.bmt.1703551

Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab

S. Hongeng
, P. Tardtong
, S. Worapongpaiboon
, A. Ungkanont
, S. Jootar

Ramathibodi Hospital

Research output: Contribution to journal › Article › peer-review

45 Citations (Scopus)

Abstract

Here, we report a case of paediatric β-thalassaemia major patient who underwent unrelated T cell-nondepleted bone marrow transplantation and developed a complication of autoimmune haemolytic anaemia (AIHA) refractory to corticosteroid and intravenous immunoglobulin therapy. After this child received two doses (375 mg/m²/dose) of rituximab (anti-CD20 monoclonal antibody), his AIHA was resolved.

Original language	English
Pages (from-to)	871-872
Number of pages	2
Journal	Bone Marrow Transplantation
Volume	29
Issue number	10
DOIs	https://doi.org/10.1038/sj.bmt.1703551
Publication status	Published - 2002

Keywords

Autoimmune haemolytic anaemia
Rituximab
Unrelated bone marrow transplantation

Access to Document

10.1038/sj.bmt.1703551

Cite this

@article{675901bac83147a0a1a58184c40d3a32,

title = "Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab",

abstract = "Here, we report a case of paediatric β-thalassaemia major patient who underwent unrelated T cell-nondepleted bone marrow transplantation and developed a complication of autoimmune haemolytic anaemia (AIHA) refractory to corticosteroid and intravenous immunoglobulin therapy. After this child received two doses (375 mg/m2/dose) of rituximab (anti-CD20 monoclonal antibody), his AIHA was resolved.",

keywords = "Autoimmune haemolytic anaemia, Rituximab, Unrelated bone marrow transplantation",

author = "S. Hongeng and P. Tardtong and S. Worapongpaiboon and A. Ungkanont and S. Jootar",

year = "2002",

doi = "10.1038/sj.bmt.1703551",

language = "English",

volume = "29",

pages = "871--872",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Springer Nature",

number = "10",

}

TY - JOUR

T1 - Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab

AU - Hongeng, S.

AU - Tardtong, P.

AU - Worapongpaiboon, S.

AU - Ungkanont, A.

AU - Jootar, S.

PY - 2002

Y1 - 2002

N2 - Here, we report a case of paediatric β-thalassaemia major patient who underwent unrelated T cell-nondepleted bone marrow transplantation and developed a complication of autoimmune haemolytic anaemia (AIHA) refractory to corticosteroid and intravenous immunoglobulin therapy. After this child received two doses (375 mg/m2/dose) of rituximab (anti-CD20 monoclonal antibody), his AIHA was resolved.

AB - Here, we report a case of paediatric β-thalassaemia major patient who underwent unrelated T cell-nondepleted bone marrow transplantation and developed a complication of autoimmune haemolytic anaemia (AIHA) refractory to corticosteroid and intravenous immunoglobulin therapy. After this child received two doses (375 mg/m2/dose) of rituximab (anti-CD20 monoclonal antibody), his AIHA was resolved.

KW - Autoimmune haemolytic anaemia

KW - Rituximab

KW - Unrelated bone marrow transplantation

UR - https://www.scopus.com/pages/publications/0035998368

U2 - 10.1038/sj.bmt.1703551

DO - 10.1038/sj.bmt.1703551

M3 - Article

C2 - 12058238

AN - SCOPUS:0035998368

SN - 0268-3369

VL - 29

SP - 871

EP - 872

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 10

ER -

Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this